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Patients with a primary or secondary diagnosis of diabetes present unique challenges 
during an inpatient hospital stay to treat an acute or chronic illness. Upon review of 
current hospital practice, an interprofessional team embarked on a performance 
improvement project to improve outcomes for the complex medical-surgical diabetic 
patient. The methods detailed in this manuscript - a comprehensive education plan, 
preceptorship and peer accountability, active engagement and support by the unit nursing 
leadership team, and interprofessional collaboration - offer strategies any organization 
can implement to positively impact diabetes care. 
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Diabetes is the fastest growing chronic disease in the United States (US). According to 
the Centers for Disease Control, there are an estimated 25.8 million persons living with 
diabetes and 79 million persons with pre-diabetes.1 If current trends continue, it is 
projected that by the year 2050, one in three people will have diabetes.  Costs for acute, 
inpatient diabetes care accounted for half of the 174 billion dollar total medical 
expenditures of the disease.2  Additionally, one in ten health care dollars is spent on 
diabetes.3  In the past decade, research has demonstrated that achieving glycemic control 
during acute illness, with or without a diabetes diagnosis, improves a variety of clinical 
outcomes, with associated financial benefits.4-8  
 
At Lehigh Valley Health Network (LVHN), an academic community Magnet® 
designated hospital in southeastern Pennsylvania, 29 % of inpatients carry a primary or 
secondary diagnosis of diabetes. For many years, our network demonstrated a 
commitment to the care of patients with diabetes or hyperglycemia through a variety of 
programs in both the acute and outpatient settings.  In 2004, in response to acute care 
glycemic control research, a multi-disciplinary Diabetes Management Quality 
Improvement Team (DM QIT) was formed and continues to present.  Figure 1 details the 
purpose and functions of the team. This manuscript details how LVHN staff members on 
a 30-bed medical-surgical unit (4K), specializing in vascular and colon-rectal surgery 
patients,  embraced the evolving clinical practice guidelines for diabetes management 
established by the DM QIT and achieved and sustained outcomes that exceed national 
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benchmarks for hyperglycemia (blood glucose {BG} > 180mg/dL) and hypoglycemia 
(BG < 70mg/dL) rates.   
 
Evidence Review 
Hyperglycemia in acute illness has been shown to increase mortality, whether or not the 
patient had a diagnosis of diabetes.9  Initial inpatient studies focused on improved clinical 
outcomes of critically ill patients with a variety of conditions, including coronary artery 
bypass surgery, general surgery, acute myocardial infarction, acute ischemic stroke, head 
trauma, and mechanical ventilation.10-23  While only a few of these studies were 
controlled randomized clinical trials, results were compelling enough that in 2004, 
national experts from the American Association of Clinical Endocrinologists (AACE) 
developed initial recommended goals for inpatient glycemic targets. These 
recommendations suggested that the upper limits of glycemic targets in the intensive care 
population should be 110 mg/dl, and for non-critically ill patients a pre-prandial glucose 
of 110 mg/dl and a maximum glucose of 180 mg/dl. 24 
 
In 2006, the American College of Endocrinology (ACE) and the American Diabetes 
Association (ADA) performed an updated evidence review and joined forces to issue a 
call to action consensus statement which provided additional recommendations to 
improve hospital inpatient glycemic control.25   As a result of these and other subsequent 
expert statements, hospital personnel across the US were challenged to make changes in 
the traditional care delivered to patients with diabetes or hyperglycemia. Based on 
continued and mounting evidence, revised glycemic targets for inpatient care now focus 
 4 
on avoiding hypoglycemia and set more liberal pre-prandial blood glucose targets at less 
than 140 mg/dl. Maximum random glucose value recommendations remain at less than 
180 mg/dl.26,27   
 
Since persons with diabetes consume an estimated 22% of all hospital inpatient days,3 
improving the quality of diabetes management became an important, but challenging, 
focus for hospital systems on many levels. No single protocol has been deemed 
superior,28  so approaches to achieve goals vary. Regardless, the newer methods and 
medication formularies to address inpatient hyperglycemia are more complicated than in 
the past. A recent study suggests knowledge related to insulin use among attending 
physicians, residents and nursing professionals is low, which is concerning given the high 
incidence of diabetes and potential adverse patient outcomes.29  
 
Although guidelines for recommended glycemic targets have been the emphasis of 
inpatient diabetes literature over the past few years, until recently there was little reported 
and collated outcome data for hospitals regarding the established goals. A survey 
published in 2009 of 126 US hospitals to gain data on glycemic controls was the first 
attempt to establish a national benchmarking process. Results identified hospital 
hyperglycemia (> 180 mg/dl) and hypoglycemia (< 70 mg/dl) prevalence rates for both 
intensive care unit (ICU) and non-ICU settings. Overall rates of hyperglycemia in non-
ICUs were 31.7% and for hypoglycemia 3.5%. 30 
 
Creating the Passion for Excellence in Glycemic Control 
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Setting the Stage 
The LVHN mission is to provide high quality patient care driven by education and 
research. As the early evidence unfolded related to the importance of glycemic control, 
4K staff members engaged in a performance improvement (PI) project that demonstrated 
a relation between improved glucose control through intravenous (IV) infusion and a 
significant reduction in infections.31  This 2001 – 2002 PI project was very progressive. 
At that time, and even today, IV insulin infusion protocols were and are not common 
practice in the majority of US hospitals, especially in the medical-surgical inpatient 
setting.  
 
During this initial PI project, 4K staff was hesitant about using IV insulin infusion due to 
the increased patient acuity and associated workload in the medical-surgical setting. 
However, the positive results demonstrating reduced infections validated the literature 
evidence first hand, prompting acceptance for IV insulin infusion.  Achieving optimal 
glycemic control became a patient care priority, ingrained in the 4K culture. Following 
the PI project, as more evidence evolved regarding the importance of inpatient glycemic 
control, we expanded and revised our glycemic care protocols. 
 
These protocols, in place throughout the network since 2008, include IV infusion and 
subcutaneous (SQ) insulin standardized order sets.  The IV infusion order set uses 
Columnar Insulin Dosing Charts developed by the Georgia Hospital Association 
Research and Education Foundation Partnership for Health and Accountability 
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(GHAREF-PHA) Stockton Diabetes Special Interest Group to achieve and maintain a 
target blood glucose range between 90 and 140 mg/dl (Figure 2).32  
 
Subcutaneous order sets utilize basal insulin in conjunction with bolus insulin based on 
carbohydrate consumption and individual insulin sensitivity factors, versus the long- 
standing practice of sliding scale insulin administration. The physician identifies a 
specific SQ dose for the designated patient, considering the patient’s individual response 
to insulin, including factors such as body weight, renal disease and infection.   
 
Strategies and Interventions   
As the above protocols were implemented throughout our network, 4K staff members 
developed a renewed passion for optimum glycemic control. Four distinct components 
were and continue to be instrumental in their continuing success: a comprehensive 
education plan; preceptorship and peer accountability; active engagement and support by 
the unit nursing leadership team; and, interprofessional collaboration. 
 
Comprehensive Education Plan  
Three learning opportunities exist for staff to develop the skills to achieve glycemic 
control. The first includes electronic learning modules. Formerly, the content of one of 
the modules was an eight hour, didactic continuing education offering. Titled, 
“Advancing Diabetes Care in the 21st Century,” it was offered quarterly to all nursing 
staff throughout the Network. Recognizing the challenges for staff nurses to attend a full 
day classroom educational program, in 2009 the course was converted into an electronic 
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format. Figure 3 details this program’s content outline. Successful completion earns 2.5 
continuing nursing education credits. While neither course was and currently is 
mandatory for all Network nurses, completion by 4K registered nurses (RNs) was and 
continues to be required.  
 
In 2008, when the IV infusion and subcutaneous insulin standardized order sets were 
instituted, electronic learning modules for each order set were developed. Content 
includes the rationale and specific procedures associated with IV and subcutaneous 
insulin administration.  Figures 4 and 5 detail, respectively, the content outline for these 
offerings. Both modules are required by RNs throughout the Network as the initial 
learning resource for these skills. Average time to complete each offering is 60 minutes.  
The 4K unit-based educator, who oversees staff member competency attainment, has the 
ability to review time spent by the learner on each module, as well as test scores. This 
information may be useful for future coaching and remediation.  
 
Six weeks prior to implementation of the new insulin order sets, as a supplement to the 
electronic learning modules, 90-minute workshops were offered by Network diabetes 
education specialists. All inpatient unit-based educators were required to attend a 
workshop, with the intent that they, in turn, would disseminate learnings to their staff. 
Recognizing the magnitude of the insulin order set implementation, 4K leaders believed 
their staff’s knowledge would be enhanced by staff members attending the workshops 
themselves, versus the ‘train the trainer’ method used by other units.  
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In addition to the aforementioned electronic learning modules, two other modules related 
to diabetes management were subsequently designed:  one details the Network’s 
hyperglycemia management clinical practice guidelines; the second reviews the concepts 
of carbohydrate counting. These modules are also required for 4K staff during their 
orientation.  
 
Following completion of the various learning modules, the second opportunity for a staff 
member to promote optimum glycemic control is a medication validation process with 
the unit based educator, prior to experience with a staff nurse preceptor. The staff nurse, 
with the educator, administers medications to her four or five primary patients.  During 
this experience, the educator assesses all aspects of medication administration, including, 
but not limited to, application of knowledge gained from the diabetes related learning 
modules. Normally, this experience is completed in one, eight-hour shift.   
 
The third opportunity associated with glycemic control competency is a two-hour 
workshop for the staff member, conducted by the unit educator. The workshop teaching 
strategy incorporates simulated case scenarios associated with IV insulin infusion, 
focusing on titrating IV insulin based on changing blood glucose levels. Figure 6 shows 
three practice examples.  Nurses are introduced to available tools which assist with 
decision making and troubleshooting, including a standardized algorithm, columnar 
dosing grid, and ‘Frequently Asked Questions’ fact sheet. Special considerations, such as 
hyperglycemic events and total parenteral nutrition, are also reviewed.  
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Preceptorship and Peer Accountability 
A second strategy for staff to gain competency and comfort with glycemic control 
principles is preceptorship with peer accountability. A formal preceptor program has been 
in place within LVHN for over 25 years.  The role of the preceptor is crucial to successful 
adaptation of the nurse to a new work environment and development of the associated 
dimensions of competent performance: critical thinking, technical and interpersonal 
relation skills.33  
 
The ‘Preceptor Preparation Program’ is eight hours in length, with continuing nursing 
education credits awarded upon successful completion. Only those staff members who 
have attended the program may serve in the preceptor role. The program reviews the 
organization’s educational framework of competency-based education and self-directed 
learning. Preceptors develop skills in prompting the learners to identify their learning 
needs, formulate goals, and select resources for learning.  
 
The unit-based educator assigns learners to a preceptor, considering a match between 
learning preferences and preceptor teaching methods. Consistent assignment of the 
learner with the preceptor is intended to build a relationship based on trust.   
 
Preceptors on 4K pay special attention for opportunities to review care of assigned 
patients with diabetes, engaging the learner in in-depth case study discussions. The 
preceptor asks probing questions of the learner, assessing critical thinking skills and 
prompting analysis to see the ‘whole picture.’  
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When a patient requires IV insulin infusion, the preceptor and learner each independently 
determine and verify the dose based on current blood sugar using the Columnar Insulin 
Dosing Charts. Following demonstration of competency by a learner, hospital policy does 
not require a second verification of IV insulin dosing; however, on 4K, staff members 
hold one another accountable for a second confirmation of the dose. This verification 
occurs upon initiation of the infusion, any change to the rate, hanging a new IV bag, 
patient transfer to or from another unit, or change of the primary RN. Such attention to 
detail is one more example of the passion by 4K staff to deliver excellent diabetes care.   
 
The preceptor and learner review progress at the end of each day, with informal goals 
identified for subsequent days. More formally, a weekly meeting occurs between the 
preceptor, learner, and unit-based educator. Strengths and areas for growth and 
development are discussed and lead to mutually determined goals for the upcoming 
week. If, during the weekly meeting, opportunities associated with diabetes patient care 
are noted, the unit-based educator provides case scenarios associated with the particular 
need for the preceptor to review with the learner. Recognizing that optimum learning 
takes place in a supportive, non-threatening environment with associated feedback,34 the 
remedial case study review builds upon the level of trust established between the 
preceptor and learner, with the ultimate outcome being confidence and demonstrated 
competency.   
 
Active Engagement and Support by the Unit Nursing Leadership Team 
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Leadership engagement and support is mandatory for any project to succeed. The 4K 
leadership team consists of the unit director, patient care specialist (PCS) and the patient 
care coordinator (PCC). The director manages all material, financial and human 
resources; the PCC provides direct patient care and, with the director, manages day-to-
day operations; and, the PCS serves as a unit-based educator.    
 
 For the past several years through the present, 4K leaders assured all unit nurses 
participate in every available educational opportunity, those designated as mandatory and 
optional. Strategically planning attendance at didactic sessions and time to complete self-
learning opportunities guarantees the learner has scheduled coverage to be relieved of 
patient care responsibilities.   
 
Upon initiation of the revised glycemic care protocols in 2008, the leadership team 
rotated responsibility to be available as a resource 24 hours per day, seven days per week.  
Each member of the team was ‘on call’ for one week at a time. Staff was responsible to 
contact the on-call leader whenever new IV or subcutaneous insulin physician orders 
occurred. The leader methodically and in great detail reviewed the order and confirmed 
dosing. The accessibility and active involvement by the leadership team members 
validated correct dosage calculation; as important, it sent the message to staff members 
that leadership recognized the more intensive work load and was willing to do their part 
to support the staff. Their actions demonstrated the Magnet™ model component of 
Transformational Leadership, specifically, conveying a strong sense of advocacy and 
support for staff.35  
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For many years, the 4K PCC has been and remains a member of the LVHN DM QIT. As 
a front-line direct caregiver, she was aware of questions and issues for clarification that 
arose during implementation of the IV infusion and subcutaneous insulin standardized 
order sets. She shared these with the DM QIT, prompting appropriate responses. This 
individual is passionate about optimum care for the patient with diabetes, serving as that 
necessary champion for cutting edge and enhanced patient care.  
 
A final strategy utilized by the unit leadership team is to regularly feature glycemic 
control information via monthly staff meetings, educational bulletin boards and 
newsletters. These methods allow staff to see the outcomes associated with their actions 
to improve glycemic control, fostering a sense of empowerment and confidence to 
influence practice,36 further stimulating forums in which staff discuss questions, 
concerns, and ideas for continuous improvement. At the same time, glycemic control 
remains ‘on the front burner,’ avoiding complacency and instead, fostering not just 
competency, but an ardor for the subject.  
 
Interprofessional Collaboration 
Practicing as a collaborative team is not an option at LVHN; it is an expectation of all 
staff members. During the site visit associated with the organization’s third designation 
as a Magnet hospital, the appraisers stated, “The physician/nurse relationship is one step 




To promote interprofessional collaboration for the patient with diabetes, it is important 
that all disciplines are aware of and knowledgeable about interdisciplinary clinical 
practice guidelines. To assure this knowledge for the physician population, attending 
hospitalists and new residents are oriented to the team approach for care of a patient with 
diabetes. A Network diabetes education specialist facilitates didactic sessions lasting one 
to two hours, reviewing the following topics: IV and SQ insulin order sets; diabetes 
medications and their pharmacological properties; and, clinical practice guidelines for 
hypoglycemia and hyperglycemia. The physicians are given pocket cards detailing 
insulin and oral medication profiles and inpatient dosing strategies. This same 
information is available as a reference on the hospital intranet and within the computer 
order entry system.  
 
Interprofessional rounds occur daily on 4K at the patient’s bedside. Team members 
include the patient and family, primary RN, attending physician, case manager, physical 
therapist, registered dietician, and 4K leadership team member. This collaborative effort 
promotes camaraderie as each team member offers information for the patient’s plan of 
care. An ‘all voices heard’ approach results in professional relationships built on trust and 
mutual respect.35 As necessary, the RN is empowered to initiate a discussion of glycemic 
control therapy if other team members do not propose the same.  
 
Unlicensed assistive personnel, termed technical partners (TPs), are an integral part of 
patient care on 4K. Their scope of responsibility includes point-of-care glucose testing, 
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with the associated expectation to report results in a timely manner. On a daily basis, at 
the beginning of each shift, the 4K RN reviews key elements influencing glycemic 




Since implementation of the revised glycemic care protocols in 2008, the Network’s DM 
QIT reviews unit glucose control data using a software program that pulls all point-of-
care blood glucose values from a data warehouse. Comparative unit data is reviewed 
quarterly. Consistently, for the past three years, 4K patients had the lowest 
hyperglycemia rate (BG > than 180mg/dl) compared to Network medical-surgical and 
step-down units which utilize the IV titration and SQ order sets. In addition, the 4K rate 
is better than the published benchmark cited earlier in this manuscript. (See Table I)  For 
the same time period, the hypoglycemia rate for 4K patients was lower than the 
benchmark and majority of the comparative units. (See Table II) 
 
Lessons Learned 
A recommendation based on our experience is to always be cognizant that insulin is a 
“high alert medication,”37 and to never become complacent, despite planned and well 
developed initial strategies related to glycemic control. Vigilant monitoring for 
compliance must be ongoing and at the forefront of continuous improvement efforts.  
 
This leads to another learning, related to insulin timing and dosage. Within our 
organization, meals are served at the time requested by the patient, versus a consistent 
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time for all patients on a designated unit. We quickly realized that a process had to be 
designed to assure that glucose monitoring, insulin administration and meals were 
appropriately timed and coordinated. Regarding insulin dosing, it is important to 
recognize there will be ongoing knowledge gaps by licensed, independent providers. One 
action we have recently taken is to require diabetes pharmacology education by 
designated providers via electronic learning modules.  
 
A final caution relates to the arrival each year of new resident physicians. Though 
glycemic control educational opportunities are communicated, attendance may not be a 
priority despite their best efforts. To address this issue, support from the residents’ 
supervising physicians must be garnered for accountability to participate in the offered 
education and demonstration of competency.  
 
 
Implications for Clinical Practice 
 
Newer methods and medication formularies to address inpatient hyperglycemia are more 
complicated than in the past. According to a study,  physician, resident, and nursing 
knowledge may not be adequate to ensure appropriate diabetes management. 31 All of 
these issues, exacerbated by the rising incidence and costs of diabetes care, challenge 
staff within hospital systems to implement best practice strategies that  result in improved 
and sustainable changes to the care of patients with diabetes. The methods detailed in this 
manuscript - a comprehensive education plan, preceptorship and peer accountability, 
active engagement and support by the unit nursing leadership team, and interprofessional 
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collaboration - offer strategies any organization can implement to positively impact 
diabetes care.  
 
Summary 
As outlined in the evidence review, improving glucose control in hospitalized patients 
improves clinical outcomes. Staff members on our 30-bed medical-surgical unit 
successfully implemented IV insulin protocols which helped us to achieve and sustain 
lower rates of hyperglycemia (BG > 180mg/dL) and hypoglycemia (BG < 70mg/dL) 
compared to national benchmarks and similar units within our own network.    
 
Our focus on comprehensive education, as well as preceptorship and peer accountability, 
are key elements to enhance staff knowledge regarding the importance of glycemic 
control and safely implement best practice strategies that are not commonplace. To 
change practice, supporting education through active leadership engagement and 
interprofessional collaboration has proven successful in our setting. Leadership 
accessibility and focus, characteristics of transformational leaders,35 serve to energize 
staff and validate that all team members are working on common goals for improved 
patient care. The ultimate outcome is an inherent culture and passion for diabetes care 
that is unique and has sustained our results over time.   
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